Project BOOST® Presents "Subcutaneous Insulin Order Sets in the Inpatient Setting: Design and Implementation"
SHM BOOST Webinar Series
Accreditation and Designation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Blackwell Futura Media Services and the Society of Hospital Medicine. Blackwell Futura Media Services is accredited by the ACCME to provide continuing medical education for physicians.”
Blackwell Futura Media Services designates this Enduring Material for a maximum of one (1) AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Upon completion of this educational activity, participants will be better able to:
- Synthesize and discuss the importance and prevalence of inpatient hyperglycemia / diabetes.
- Identify and describe current guidelines for glucose targets in the inpatient setting, the rationale for the targets, and the optimal methods to achieve the glycemic target safely in non-critical care settings.
- Identify appropriate insulin dosing and management for inpatients, and design proficient insulin regimens for patients in different situations (NPO, tube feeding, TPN, unexpected interruption of nutrition, etc.)
- Outline methods to manage transitions into the hospital, from infusion to subcutaneous insulin, and out of the hospital.
- Identify the important elements for a successful effort to improve the quality and safety of inpatient insulin management and how to ‘hard wire’ improvements into the system.
Activity Director: Jeffrey Greenwald, MD, SFHM
Presenters: Kristi Kulasa MD
No commercial support has been accepted related to the development or publication of this activity.
Kristi Kulasa has no conflicts of interest to disclose.
SHM complies with ACCME Standards for Commercial Support by following policies and procedures designed to identify and manage conflicts of interest in Company-supported Society CME programs at all stages in program design and implementation. All programs are developed independent of any sponsor input and do not allow the use of trade names. Furthermore, SHM instructs faculty to present a balanced view of treatment options and reviews material to make sure this is the case. SHM is transparent about all funding received.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation (non-CME)